(Q28275022)

9

object named as

Alexander I Klimov

0 references

Nancy Cox

8

object named as

Nancy J Cox

0 references

author name string

Marie-jo Medina

2

0 references

Xiyan Xu

3

0 references

Gilda Perez-Oronoz

4

0 references

Teresa R Wallis

5

0 references

Xiaohong M Davis

6

0 references

Laura Povinelli

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

7

0 references

language of work or name

English

0 references

publication date

1 October 2005

0 references

published in

The Lancet

0 references

volume

366

0 references

page(s)

1175-81

0 references

issue

9492

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Biologic potential of amantadine-resistant influenza A virus in an avian model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Molecular basis of resistance of influenza A viruses to amantadine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Low incidence of rimantadine resistance in field isolates of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Intercontinental Circulation of Human Influenza A(H1N2) Reassortant Viruses during the 2001–2002 Influenza Season

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Influenza: global surveillance for epidemic and pandemic variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

H5N1 influenza: a protean pandemic threat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

The genome sequence analysis of H5N1 avian influenza A virus isolated from the outbreak among poultry populations in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967338-2

7 January 2021

10.1016/S0140-6736(05)67338-2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1427864

1427864

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference